130 related articles for article (PubMed ID: 23025805)
1. Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors.
Liu T; Nair SJ; Lescarbeau A; Belani J; Peluso S; Conley J; Tillotson B; O'Hearn P; Smith S; Slocum K; West K; Helble J; Douglas M; Bahadoor A; Ali J; McGovern K; Fritz C; Palombella VJ; Wylie A; Castro AC; Tremblay MR
J Med Chem; 2012 Oct; 55(20):8859-78. PubMed ID: 23025805
[TBL] [Abstract][Full Text] [Related]
2. Simplified silvestrol analogues with potent cytotoxic activity.
Hawkins BC; Lindqvist LM; Nhu D; Sharp PP; Segal D; Powell AK; Campbell M; Ryan E; Chambers JM; White JM; Rizzacasa MA; Lessene G; Huang DC; Burns CJ
ChemMedChem; 2014 Jul; 9(7):1556-66. PubMed ID: 24677741
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies.
Rodrigo CM; Cencic R; Roche SP; Pelletier J; Porco JA
J Med Chem; 2012 Jan; 55(1):558-62. PubMed ID: 22128783
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of biotinylated episilvestrol: highly selective targeting of the translation factors eIF4AI/II.
Chambers JM; Lindqvist LM; Webb A; Huang DC; Savage GP; Rizzacasa MA
Org Lett; 2013 Mar; 15(6):1406-9. PubMed ID: 23461621
[TBL] [Abstract][Full Text] [Related]
5. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships.
Sarek J; Klinot J; Dzubák P; Klinotová E; Nosková V; Krecek V; Korínková G; Thomson JO; Janost'áková A; Wang S; Parsons S; Fischer PM; Zhelev NZ; Hajdúch M
J Med Chem; 2003 Dec; 46(25):5402-15. PubMed ID: 14640549
[TBL] [Abstract][Full Text] [Related]
6. A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency.
Signori E; Bagni C; Papa S; Primerano B; Rinaldi M; Amaldi F; Fazio VM
Oncogene; 2001 Jul; 20(33):4596-600. PubMed ID: 11494157
[TBL] [Abstract][Full Text] [Related]
7. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol.
Cencic R; Carrier M; Galicia-Vázquez G; Bordeleau ME; Sukarieh R; Bourdeau A; Brem B; Teodoro JG; Greger H; Tremblay ML; Porco JA; Pelletier J
PLoS One; 2009; 4(4):e5223. PubMed ID: 19401772
[TBL] [Abstract][Full Text] [Related]
9. Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells.
Gupta SV; Sass EJ; Davis ME; Edwards RB; Lozanski G; Heerema NA; Lehman A; Zhang X; Jarjoura D; Byrd JC; Pan L; Chan KK; Kinghorn AD; Phelps MA; Grever MR; Lucas DM
AAPS J; 2011 Sep; 13(3):357-64. PubMed ID: 21538216
[TBL] [Abstract][Full Text] [Related]
10. The natural compound silvestrol is a potent inhibitor of Ebola virus replication.
Biedenkopf N; Lange-Grünweller K; Schulte FW; Weißer A; Müller C; Becker D; Becker S; Hartmann RK; Grünweller A
Antiviral Res; 2017 Jan; 137():76-81. PubMed ID: 27864075
[TBL] [Abstract][Full Text] [Related]
11. Correlation of cytotoxic activity of betulinines and their hydroxy analogues.
Sarek J; Kvasnica M; Urban M; Klinot J; Hajduch M
Bioorg Med Chem Lett; 2005 Oct; 15(19):4196-200. PubMed ID: 16051489
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of antitumor-active gamma-butyrolactone substituted betulin derivatives.
Csuk R; Barthel A; Schwarz S; Kommera H; Paschke R
Bioorg Med Chem; 2010 Apr; 18(7):2549-58. PubMed ID: 20299226
[TBL] [Abstract][Full Text] [Related]
13. Hemisynthetic secofriedelane triterpenes with inhibitory activity against the growth of human tumor cell lines in vitro.
Moiteiro C; Manta C; Justino F; Tavares R; Curto MJ; Pedro M; Nascimento MS; Pinto M
J Nat Prod; 2004 Jul; 67(7):1193-6. PubMed ID: 15270581
[TBL] [Abstract][Full Text] [Related]
14. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.
Hwang BY; Su BN; Chai H; Mi Q; Kardono LB; Afriastini JJ; Riswan S; Santarsiero BD; Mesecar AD; Wild R; Fairchild CR; Vite GD; Rose WC; Farnsworth NR; Cordell GA; Pezzuto JM; Swanson SM; Kinghorn AD
J Org Chem; 2004 May; 69(10):3350-8. PubMed ID: 15132542
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
16. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity correlation of natural-product inspired cyclodepsipeptides stabilizing F-actin.
Tannert R; Milroy LG; Ellinger B; Hu TS; Arndt HD; Waldmann H
J Am Chem Soc; 2010 Mar; 132(9):3063-77. PubMed ID: 20148556
[TBL] [Abstract][Full Text] [Related]
18. Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions.
Pontrelli L; Sidiropoulos KG; Adeli K
Biochemistry; 2004 Jun; 43(21):6734-44. PubMed ID: 15157107
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
[TBL] [Abstract][Full Text] [Related]
20. Silvestrol regulates G2/M checkpoint genes independent of p53 activity.
Mi Q; Kim S; Hwang BY; Su BN; Chai H; Arbieva ZH; Kinghorn AD; Swanson SM
Anticancer Res; 2006; 26(5A):3349-56. PubMed ID: 17094452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
